Stock listing
Sam Chun Dang Pharm. Co., Ltd.
Selected listing: 000250 · KRX · KRW · KR
Sam Chun Dang Pharm. Co., Ltd. (KRX:000250), Health Technology. Latest release May 29, 2026: Sam Chun Dang Pharm Co European Medicines Agency Approves Phase I…
- Ticker
- KRX:000250
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- KRX
- Currency
- KRW
About Sam Chun Dang Pharm. Co., Ltd.
Sam Chun Dang Pharm. Co., Ltd. is a public company traded under the ticker 000250 on the Korean market. It focuses on developing and manufacturing a range of healthcare products.
Latest news from Sam Chun Dang Pharm. Co., Ltd.
Sam Chun Dang Pharm Co European Medicines Agency Approves Phase I Clinical Study Plan On Oral Insulin In Germany
May 28, 2026
Sam Chun Dang Pharm Co To Buy 9.9 Billion Won Worth Of Shares In Optus Pharmaceutical
October 22, 2025
Citibank Korea geared for water purification at Gyeongin Ara Waterway
August 24, 2014
Citibank Korea Inc. launches the new Shinsegae Citi Rewards Card
November 19, 2011
Research Sam Chun Dang Pharm. Co., Ltd.
Sam Chun Dang Pharm. Co., Ltd. company profile
View the public company page for Sam Chun Dang Pharm. Co., Ltd. on 6ix.
Sam Chun Dang Pharm. Co., Ltd. news
Read company news and market updates connected to Sam Chun Dang Pharm. Co., Ltd..
Sam Chun Dang Pharm. Co., Ltd. investor events
Find investor webinars, events, and replay context for Sam Chun Dang Pharm. Co., Ltd..